PositiveID (PositiveID) EV-to-Revenue : 0.00 (As of Jun. 06, 2024)

View and export this data going back to 2007. Start your Free Trial

What is PositiveID EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PositiveID's enterprise value is $0.00 Mil. PositiveID's Revenue for the trailing twelve months (TTM) ended in Mar. 2018 was $4.55 Mil. Therefore, PositiveID's EV-to-Revenue for today is 0.00.

The historical rank and industry rank for PositiveID's EV-to-Revenue or its related term are showing as below:

PSID's EV-to-Revenue is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 3.085
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-06), PositiveID's stock price is $0.0001. PositiveID's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2018 was $290.04. Therefore, PositiveID's PS Ratio for today is 0.00.

PositiveID EV-to-Revenue Historical Data

The historical data trend for PositiveID's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PositiveID EV-to-Revenue Chart

PositiveID Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

EV-to-Revenue

Get a 7-Day Free Trial

1.35

1.41

PositiveID Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
EV-to-Revenue	Get a 7-Day Free Trial															1.27	1.39	1.70	1.41	1.66

Competitive Comparison of PositiveID's EV-to-Revenue

For the Diagnostics & Research subindustry, PositiveID's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PositiveID's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PositiveID's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PositiveID's EV-to-Revenue falls into.

PositiveID EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PositiveID's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.000	/	4.552
	=	0.00

PositiveID's current Enterprise Value is $0.00 Mil.
PositiveID's Revenue for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.55 Mil.

PositiveID (OTCPK:PSID) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PositiveID's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0001	/	290.036
	=	0.00

PositiveID's share price for today is $0.0001.
PositiveID's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $290.04.

PositiveID EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PositiveID's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PositiveID (PositiveID) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PositiveID Corp (OTCPK:PSID) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1690 South Congress Avenue, Suite 201, Delray Beach, FL, USA, 33445

Website

http://www.psidcorp.com

PositiveID Corp is a life science tools and diagnostics company. It specializes in the biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. The business activity of the firm includes the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its subsidiary. Further, it is also involved in the development of FireflyDX family of products, automated pathogen detection system for rapid diagnostics, both for clinical and point-of-need applications. In addition, it also manufactures specialty technology vehicles focused primarily on mobile laboratory and communications applications. All the activities are carried out through the US.

Executives

Ned L Siegel	director	600 WILSHIRE BOULEVARD, LOS ANGELES CA 90017
Michael E Krawitz	director	1690 S CONGRESS AVE, STE 201, DELRAY BEACH FL 33445
Barry M Edelstein	director	1100 GREEN VALLEY ROAD, BRYN MAWR PA 19010
Scott R Silverman	other: Former 10% Owner
Marxe Austin W & Greenhouse David M	10 percent owner	C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Weaver Constance K	director	2900 ESPERANZA CROSSING, 2ND FLOOR, AUSTIN TX 78758
Tommy G Thompson	director	7711 CARONDELET, ST. LOUIS MO 63105